We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+5.78%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$202M
AUM Growth
-$20.4M
(-9.2%)
Cap. Flow
-$72M
Cap. Flow
% of AUM
-35.68%
Top 10 Holdings %
Top 10 Hldgs %
32.61%
Holding
161
New
27
Increased
32
Reduced
22
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Everspin Technologies
MRAM
|
+$3.23M |
| 2 |
Mirum Pharmaceuticals
MIRM
|
+$1.21M |
| 3 |
Lantronix
LTRX
|
+$1.2M |
| 4 |
SCYNEXIS
SCYX
|
+$920K |
| 5 |
Context Therapeutics
CNTX
|
+$872K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMKR
Emcore Corp
EMKR
|
+$5.2M |
| 2 |
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
|
+$3.83M |
| 3 |
ADMS
Adamas Pharmaceuticals
ADMS
|
+$3.1M |
| 4 |
OIIM
02Micro International
OIIM
|
+$2.06M |
| 5 |
Aviat Networks
AVNW
|
+$1.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 11.1% |
| 3 | Financials | 3.75% |
| 4 | Consumer Discretionary | 3.07% |
| 5 | Real Estate | 1.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALIM
51
DELISTED
Alimera Sciences
ALIM
| $636K | 0.32% |
123,947
-3,386
| -3% | -$16.6K |
|
|
EMKR
52
DELISTED
Emcore Corp
EMKR
| $614K | 0.3% |
8,789
-70,582
| -89% | -$5.2M |
|
53
Ardelyx
ARDX
$1.22B
| $606K | 0.3% |
+550,975
| New | +$654K |
|
|
ALNA
54
DELISTED
Allena Pharmaceuticals
ALNA
| $581K | 0.29% |
980,200
| – | – |
|
55
PDS Biotechnology
PDSB
$38.4M
| $574K | 0.28% |
70,803
-106,786
| -60% | -$1.15M |
|
56
Ideal Power
IPWR
$60.8M
| $558K | 0.28% |
46,275
+12,703
| +38% | +$170K |
|
|
CTO
57
CTO Realty Growth
CTO
$824M
| $487K | 0.24% |
23,790
| – | – |
|
|
58
Context Therapeutics
CNTX
$55.1M
| $465K | 0.23% |
+174,967
| New | +$872K |
|
59
Bridgeline Digital
BLIN
$14.6M
| $461K | 0.23% |
204,025
| – | – |
|
60
Wells Fargo
WFC
$261B
| $454K | 0.22% |
9,459
-9,516
| -50% | -$468K |
|
|
CIO
61
DELISTED
City Office REIT
CIO
| $449K | 0.22% |
22,750
-1,000
| -4% | -$18.4K |
|
62
Franklin Wireless
FKWL
$26.9M
| $432K | 0.21% |
98,826
-98,826
| -50% | -$462K |
|
|
CMBM
63
DELISTED
Cambium Networks
CMBM
| $397K | 0.2% |
+15,505
| New | +$449K |
|
|
YTEN
64
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| $392K | 0.19% |
3,320
| – | – |
|
65
Abeona Therapeutics
ABEO
$366M
| $383K | 0.19% |
+45,491
| New | +$836K |
|
|
BWAY
66
Brainsway
BWAY
$611M
| $359K | 0.18% |
93,242
-107,958
| -54% | -$429K |
|
67
Processa Pharmaceuticals
PCSA
$5.95M
| $348K | 0.17% |
142
-40
| -22% | -$124K |
|
68
Solana Company
HSDT
$96.3M
| $298K | 0.15% |
+2
| New | +$712K |
|
69
Rezolute
RZLT
$454M
| $290K | 0.14% |
+60,718
| New | +$355K |
|
|
EQC
70
DELISTED
Equity Commonwealth
EQC
| $285K | 0.14% |
11,003
| – | – |
|
71
Vail Resorts
MTN
$5.32B
| $282K | 0.14% |
+860
| New | +$293K |
|
72
Kite Realty
KRG
$5.81B
| $280K | 0.14% |
+12,850
| New | +$275K |
|
73
Blackstone Mortgage Trust
BXMT
$2.45B
| $257K | 0.13% |
8,400
+900
| +12% | +$28.6K |
|
74
DexCom
DXCM
$31.5B
| $252K | 0.12% |
1,880
+200
| +12% | +$28.7K |
|
75
Alico
ALCO
$280M
| $213K | 0.11% |
+5,763
| New | +$206K |
|
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Worth Venture Partners held 161 positions worth $202M, down 9.2% from $222M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Worth Venture Partners withdrew a net $72M in Q4 2021, closing 30 positions and reducing 22 holdings. Its most notable exit was Galera Therapeutics, Inc. Common Stock, an estimated $3.83M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Worth Venture Partners opened a new position in Everspin Technologies worth $4.03M.
- Worth Venture Partners's largest Q4 2021 buy was Everspin Technologies: 356,722 shares worth $4.03M.
- Worth Venture Partners added most to SCYNEXIS in Q4 2021, an estimated $920K increase.
- Worth Venture Partners's biggest Q4 2021 reduction was Emcore Corp, cutting an estimated $5.2M.
- Worth Venture Partners fully exited Galera Therapeutics, Inc. Common Stock in Q4 2021, selling an estimated $3.83M.
- Worth Venture Partners's ten largest holdings make up 33% of its $202M portfolio in Q4 2021.
- Worth Venture Partners opened 27 new positions and closed 30 in Q4 2021.
- Worth Venture Partners's portfolio value fell 9.2% quarter-over-quarter to $202M.
Based on Worth Venture Partners's 13F filing for Q4 2021, filed 14 Feb 2022.